Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by DELLiciouson Jan 30, 2020 11:45am
96 Views
Post# 30620115

RE:RE:Really just confused

RE:RE:Really just confusedI highly doubt that anything will change in 2 months or until later this year when all the systems are running at full capacity. If experience of the past 18 months has taught me anything that is not to get excited about anything APHA related for more than a few minutes. Stock price went up 40% in one day after announcing the profitability. And then APHA did it once again and it was 10%. Third time they did that it was at 0%. 45% increase in retail sales while everyone else saw significant drops in retail sales did not matter one single tiny bit. Imagine what the 'market' reaction would have been had WEED or ACB announced something like that??

CIBC (for the most part), Anonymous and TD (as of lately) have APHA by their proverbial donuts and are keeping the price at ~$6.5 whether we want it or not. At this point of time, I'm inclined to think that only a major JV or partnership with someone gigantic would help the cause. Anything else, including a $100 million 'strategic institutional' investment won't do anything other than further extend the agony of waiting for sp to go up. Patience is a virtue indeed, although quite often it is questionable. 
Bullboard Posts